Company Profile

Autonomous Therapeutics Inc
Profile last edited on: 8/24/21      CAGE: 7T4N4      UEI: JFHPX6TUYMU8

Business Identifier: Varient-proof antivirals
Year Founded
2017
First Award
2020
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

101 6th Avenue
New York, NY 10013
   (301) 502-7772
   info@autonomous.bio
   www.autonomous.bio
Location: Multiple
Congr. District: 10
County: Kings

Public Profile

With facilities in New York, NY and in Rockville, MD and having strong ties to Harvard Medical and UCSF, Autonomous Therapeutics Inc is structured around development of broad-spectrum resistance-proof antivirals. An alumni of the NYC JLabs. and having a straight to Phase II DARPA SBIR Award, the firm's interdisciplinary team of virologists, synthetic biologists & robotics engineers are working on first-in-class pan-genus, broad-spectrum antivirals from COVID-19 to influenza. The driving theme is to ensure that effective countermeasures are ready before the next pandemic emerges.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 2 DARPA $2,247,758
Project Title: First-in-Human Therapeutic Interfering Particle (TIP) Targeting a Respiratory Virus

Key People / Management

  Ariel Weinberger -- Co-Founder and Chief Executive Officer

  Sayantan Bose -- Senior Scientist, Virology

  Kristina Brazhnik -- Senior Scientist

  Emily Forster -- Research Scientist

  Timothy Notton -- Vice President of Engineering

  Anton Shemetov -- Senior Scientist

Company News

There are no news available.